Involvement of ABC transporters in chemosensitivity of human renal cell carcinoma, and regulation of MRP2 expression by conjugated bilirubin
| Autor: | Masaaki, Nomura, Toshio, Matsunami, Kayoko, Kobayashi, Tadao, Uchibayashi, Kiyoshi, Koshida, Motohiro, Tanaka, Mikio, Namiki, Yasuharu, Mizuhara, Tetsuo, Akiba, Koichi, Yokogawa, Shuzo, Moritani, Ken-Ichi, Miyamoto |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Membrane Transport Proteins
Antineoplastic Agents Bilirubin Kidney Neoplasms Multidrug Resistance-Associated Protein 2 Inhibitory Concentration 50 Tumor Cells Cultured Humans ATP-Binding Cassette Transporters RNA Messenger Cisplatin Drug Screening Assays Antitumor Multidrug Resistance-Associated Proteins Carcinoma Renal Cell |
| Zdroj: | Anticancer research. 25(4) |
| ISSN: | 0250-7005 |
| Popis: | In this study, the involvement of ATP-binding cassette (ABC) transporters in in vitro chemosensitivity of surgically removed human renal cell carcinomas was investigated. The relative expression levels of transporter mRNAs in the renal tumors from 13 patients were similar to those in the surrounding normal kidney tissues. Five renal cell carcinomas cultured successfully in vitro for 14 days showed significantly decreased expression of multi-drug resistance-associated proteins 2 and 6 (MRP2 and MRP6) mRNAs. In vitro chemosensitivity testing of the same specimens using the collagen-gel matrix assay indicated that some anticancer drugs were effective, especially cisplatin, which is an MRP2 substrate. MRP2 mRNA expression in renal carcinoma was significantly increased when cells were cultured in the presence of conjugated bilirubin. In an established renal proximal tubule epithelial cell line (RPTEC), conjugated bilirubin increased MRP2 expression at the mRNA and protein levels, and decreased the cisplatin sensitivity of the cells. These results indicate that MRP2 expression in renal cell carcinoma may be regulated by conjugated bilirubin in the body and decreased during in vitro culture. Thus, the effectiveness of anticancer drugs selected on the basis of in vitro chemosensitivity testing of clinical cancers may be overestimated. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|